Press Releases
Press Releases: RAFARMA PHARMACEUTICALS INC
Rafarma Finalizes Acquisition of Laskavy Patents, Prepared as Global Markets Reset
April 16, 2020
Ljubljana, Slovenia, April 16, 2020 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” - Rafarma Pharmaceuticals, Inc. is pleased to announce the acquisition of all outstanding US and Australian patents from Vladislav Laskavy, Ph.D. Read More
April 6, 2020
Ljubljana, Slovenia, April 06, 2020 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” - In establishing its Advisory Board, Rafarma Pharmaceuticals announces the appointment of its first board member, Vladislav N. Laskavy,PhD. Read More
Rafarma Has Agreed to Terms to Open its First Specialized Cannabis Spa in Europe
March 23, 2020
Ljubljana, Slovenia, March 23, 2020 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” - Rafarma Pharmaceuticals, Inc. is pleased to announce that it has successfully completed negotiations with Albopark Ocio SL (a New Heled Spain Holding company), which is the owner of the Hotel Albons in Girona, Spain.Read More
Shareholder Update Letter From Rafarma CEO V. Dolgolenko
March 6, 2020
Ljubljana, Slovenia, March 06, 2020 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” Dear Shareholders: Since a recent teleconference call was held with shareholders there have been many things that have taken place. Read More
Rafarma Has Officially Begun Research Programs with Khon Kaen University in Thailand
February 24, 2020
Ljubljana, Slovenia, Feb. 24, 2020 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” is pleased to inform its shareholders that the previously-announced specialized research project between Rafarma and Khon Kaen University officially commenced on February 19, 2020.Read More
February 10, 2020
Ljubljana, Slovenia, Feb. 10, 2020 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” Rafarma is moving forward with its research initiatives for medicinal cannabis in Thailand. The research programs initiated by Rafarma will be focused mainly on developing precise protocols for the treatment of insomnia, depression, and anxiety within the facilities of Specialized Spas that will include Cannabis in their spa programs. Read More
Rafarma – MTP Partnership to Open Specialized Spas Offering Cannabis Treatments in Thailand
January 27, 2020
Ljubljana, Slovenia, Jan. 27, 2020 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” Following on the recently-announced partnership between Rafarma Pharmaceuticals, Inc. and Thailand’s MTP Material Co. Ltd., Rafarma is pleased to announce the commencement of its Specialized Detox Centers project in Thailand. The company and its partners are currently in search of a suitable location for a pilot spa in Phuket, Thailand. Read More
Rafarma Closes Exclusive Joint Venture Contract with Thailand Cannabis Partner
January 21, 2020
Ljubljana, Slovenia, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. “OTC:(RAFA)” is happy to announce the execution of an exclusive joint venture agreement with MTP MATERIAL CO. LTD. (“MTP”). This marks the first time a U.S. company has entered the Thailand cannabis industry with an agreement of this kind. Read More
Rafarma Adds Thai Corporate Officer to Solidify Market Entry in Thailand Cannabis Industry
January 9, 2020
Ljubljana, Slovenia, Jan. 09, 2020 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)”. Rafarma Pharmaceuticals, Inc. is pleased to welcome a new Executive Vice-President for Thai operations, Mr. Anucha Phetpheng. Mr. Phetpheng, 55, resides both in Bangkok and Phuket, Thailand with his wife and three children. Mr. Phetpheng brings to the company an extensive experience of top management positions in several Thailand-based companies. In Rafarma Pharmaceuticals, Mr. Phetpheng will be instrumental in running the upcoming Thai operations of the company and in getting the most synergy between the company’s European and Thai cannabis cultivation operations. Read More
November 8, 2019
Ljubljana, Slovenia, Nov. 08, 2019 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” Rafarma Pharmaceuticals, Inc. announces that following meetings this past week in Bangkok and Khon Kaen, Thailand, it has signed a Letter of Intent to acquire a 49% interest in a Thailand company which is already positioned to be a leader in the Thailand cannabis industry. Read More
September 3, 2019
Ljubljana, Slovenia, Sept. 03, 2019 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” - Rafarma Pharmaceuticals, Inc. announces the cancellation of all outstanding Preferred Class A shares. On August 28th, 2019, The company’s Board of Directors unanimously voted to cancel the 30,000,000 previously-issued Class A Preferred Shares. Read More]
Rafarma to Commence Production in Thailand; Predicted to Be The Region’s “Cannabis Capital”
August 23, 2019
Ljubljana, Slovenia, Aug. 23, 2019 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA) - Rafarma is positioning to expand its operations in the “next big thing” in cannabis production—Thailand. Rafarma is currently in talks with Thai partners to open cannabis farms and specialized cannabis spa and detox centers in Thailand. Projected plans are to construct hemp growing greenhouses as well as a specialized spa/detox center with full-control patient living facilities the following year on approximately 1000 rai (160 hectares) in the Ranong province of Thailand.[Read More]
Rafarma’s Agri-Tech Keeping Cannabis Production “High”
August 22, 2019
Ljubljana, Slovenia, Aug. 22, 2019 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA) - Rafarma is continuing to actively promote its hemp oil products in the European market. Despite the adverse weather conditions in the 2019 growing season, the quality of the company's harvested crop remained high—due to Rafarma’s practice of using only high-quality organic fertilizers and avoiding mineral fertilizers or pesticides. In particular, the use of Agropharm, a water-based extract of bio humus, allows growth production in conditions approximating black humus in virgin land.[Read More]
RAFARMA Welcomes New CEO Vladimir Dolgolenko
July 12, 2019
Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to the appointment of Vladimir Dolgolenko as its new CEO and President. Vladimir G. Dolgolenko, who resides in Slovenia, received his degrees from the Moscow State Foreign Language University (1984) and Moscow Aviation Institute (1989). Mr. Dolgolenko has earned a Masters degree in Economics and is fluent in English, Russian, Spanish and Swedish.[Read More]
RAFARMA’s Blockchain Tech Ready for Thailand’s Approved Uses of Cannabis
July 08, 2019
Ljubljana, Slovenia, July 08, 2019 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. (OTC: RAFA), is pleased to announce the commencement of negotiations with the government of the Kingdom of... [Read More]
RAFARMA Adds Blockchain Tech to Cannabis Distribution
June 19, 2019
Ljubljana, Slovenia, June 19, 2019 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals Inc (OTC: RAFA), a Wyoming Corporation, is pleased to announce an agreement with Aetsoft LLC. Aetsoft is one of the... [Read More]
Rafarma Announces Acquisition of Aeroponic Technology Expecting to Quadruple Production
June 07, 2019
Ljubljana, Slovenia, June 07, 2019 (GLOBE NEWSWIRE) -- Rafarma (OTC: RAFA), a Wyoming Corporation, is pleased to announce that it has entered into a technology acquisition agreement with Dr. Yury... [Read More]
Rafarma: Now “Growing” More Than Ever!
May 31, 2019
Ljubljana, Slovenia, May 31, 2019 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)”, a Wyoming Corporation, is pleased to announce approval of its application for farming cannabis in... [Read More]
Rafarma Joins with Glorija Kotnik to New Victories
May 30, 2019
Ljubljana, Slovenia , May 30, 2019 (GLOBE NEWSWIRE) -- Rafarma (OTC: RAFA), a Wyoming Corporation, has hired internationally acclaimed professional snowboarder Glorija Kotnik as its spokesperson and... [Read More]